Anaphylactic Tests in Model Tumour Antigen Investigations
Author Information
Author(s): M. Maureen Dale
Primary Institution: University College, London
Hypothesis
If a tumour antigen exists in a tumour and is also present in the serum, can it be detected by anaphylactic tests?
Conclusion
Anaphylactic tests do not have a very high sensitivity or discriminatory capacity for detecting tumour antigens.
Supporting Evidence
- Anaphylactic tests gave a high percentage of false negative results.
- Detection of the mock cancer antigen was inconsistent, especially at lower concentrations.
- The histamine-release test was found to be more reliable than the Dale-Schultz test.
Takeaway
The study tested if a cancer marker could be found in blood using allergy tests, but it often couldn't be detected.
Methodology
Guinea-pigs were sensitized with mock tumour extracts and tested for anaphylactic responses using the Dale-Schultz reaction and histamine release measurements.
Potential Biases
Potential bias due to inadequate sensitization and the effects of desensitization on tissue response.
Limitations
The study's findings may not apply to real tumours, and the tests had a high rate of false negatives.
Participant Demographics
Guinea-pigs were used as the animal model.
Statistical Information
P-Value
0.025
Statistical Significance
p<0.025
Want to read the original?
Access the complete publication on the publisher's website